Anna Robelius

Chromatin landscape and epigenetic heterogeneity of acute myeloid leukaemia

Ochi, Yotaro; Liew-Littorin, Markus; Nannya, Yasuhito; Bengtzen, Sofia et al.

Part of Nature, p. 752-762, 2026

• DOI for Chromatin landscape and epigenetic heterogeneity of acute myeloid leukaemia
• Download full text (pdf) of Chromatin landscape and epigenetic heterogeneity of acute myeloid leukaemia

Exploratory study linking plasma proteomics to cardiotoxicity in Hodgkin lymphoma

Mattson Ulfstedt, Johan; Risebro, Ragnhild; Freyhult, Eva; Christersson, Christina et al.

Part of Cardio-Oncology, 2026

• DOI for Exploratory study linking plasma proteomics to cardiotoxicity in Hodgkin lymphoma
• Download full text (pdf) of Exploratory study linking plasma proteomics to cardiotoxicity in Hodgkin lymphoma

Second‐ and Third‐Line Salvage Chemotherapy Followed by Allogeneic Stem Cell Transplantation Leads to High Survival Rates in Primary Refractory AML: A Population‐Based Study

Liew‐Littorin, Markus; Deleskog‐Spångberg, Linn; Deneberg, Stefan; Janosi, Judit et al.

Part of European Journal of Haematology, p. 423-432, 2025

• DOI for Second‐ and Third‐Line Salvage Chemotherapy Followed by Allogeneic Stem Cell Transplantation Leads to High Survival Rates in Primary Refractory AML: A Population‐Based Study
• Download full text (pdf) of Second‐ and Third‐Line Salvage Chemotherapy Followed by Allogeneic Stem Cell Transplantation Leads to High Survival Rates in Primary Refractory AML: A Population‐Based Study

Second‐ and Third‐Line Salvage Chemotherapy Followed by Allogeneic Stem Cell Transplantation Leads to High Survival Rates in Primary Refractory AML—A Population‐Based Study

Liew‐Littorin, Markus; Deleskog‐Spångberg, Linn; Deneberg, Stefan; Janosi, Judit et al.

Part of European Journal of Haematology, p. 423-432, 2025

• DOI for Second‐ and Third‐Line Salvage Chemotherapy Followed by Allogeneic Stem Cell Transplantation Leads to High Survival Rates in Primary Refractory AML—A Population‐Based Study

Exploratory study linking plasma proteomics to cardiotoxicity in Hodgkin lymphoma

Ulfstedt, Johan Mattsson; Risebro, Ragnhild; Freyhult, Eva; Christersson, Christina et al.

Part of Cardio-Oncology, 2025

• DOI for Exploratory study linking plasma proteomics to cardiotoxicity in Hodgkin lymphoma

Chromatin landscape and epigenetic heterogeneity of acute myeloid leukaemia

Ochi, Yotaro; Liew-Littorin, Markus; Nannya, Yasuhito; Bengtzen, Sofia et al.

Part of Nature, p. 752-762, 2026

• DOI for Chromatin landscape and epigenetic heterogeneity of acute myeloid leukaemia
• Download full text (pdf) of Chromatin landscape and epigenetic heterogeneity of acute myeloid leukaemia

Exploratory study linking plasma proteomics to cardiotoxicity in Hodgkin lymphoma

Mattson Ulfstedt, Johan; Risebro, Ragnhild; Freyhult, Eva; Christersson, Christina et al.

Part of Cardio-Oncology, 2026

• DOI for Exploratory study linking plasma proteomics to cardiotoxicity in Hodgkin lymphoma
• Download full text (pdf) of Exploratory study linking plasma proteomics to cardiotoxicity in Hodgkin lymphoma

Second‐ and Third‐Line Salvage Chemotherapy Followed by Allogeneic Stem Cell Transplantation Leads to High Survival Rates in Primary Refractory AML: A Population‐Based Study

Liew‐Littorin, Markus; Deleskog‐Spångberg, Linn; Deneberg, Stefan; Janosi, Judit et al.

Part of European Journal of Haematology, p. 423-432, 2025

• DOI for Second‐ and Third‐Line Salvage Chemotherapy Followed by Allogeneic Stem Cell Transplantation Leads to High Survival Rates in Primary Refractory AML: A Population‐Based Study
• Download full text (pdf) of Second‐ and Third‐Line Salvage Chemotherapy Followed by Allogeneic Stem Cell Transplantation Leads to High Survival Rates in Primary Refractory AML: A Population‐Based Study

Second‐ and Third‐Line Salvage Chemotherapy Followed by Allogeneic Stem Cell Transplantation Leads to High Survival Rates in Primary Refractory AML—A Population‐Based Study

Liew‐Littorin, Markus; Deleskog‐Spångberg, Linn; Deneberg, Stefan; Janosi, Judit et al.

Part of European Journal of Haematology, p. 423-432, 2025

• DOI for Second‐ and Third‐Line Salvage Chemotherapy Followed by Allogeneic Stem Cell Transplantation Leads to High Survival Rates in Primary Refractory AML—A Population‐Based Study

Exploratory study linking plasma proteomics to cardiotoxicity in Hodgkin lymphoma

Ulfstedt, Johan Mattsson; Risebro, Ragnhild; Freyhult, Eva; Christersson, Christina et al.

Part of Cardio-Oncology, 2025

• DOI for Exploratory study linking plasma proteomics to cardiotoxicity in Hodgkin lymphoma

Validation of Guidelines for Genetic Investigation of Myeloid Neoplasms with Germline Predisposition: Results from a Prospective Cohort Study

Tesi, Bianca; Robelius, Anna; Baskin, Berivan; Lazarevic, Vladimir et al.

Part of Clinical Cancer Research, p. 3062-3071, 2025

• DOI for Validation of Guidelines for Genetic Investigation of Myeloid Neoplasms with Germline Predisposition: Results from a Prospective Cohort Study
• Download full text (pdf) of Validation of Guidelines for Genetic Investigation of Myeloid Neoplasms with Germline Predisposition: Results from a Prospective Cohort Study

Somatic Exonic Deletions in RUNX1 Constitutes a Novel Recurrent Genomic Abnormality in Acute Myeloid Leukemia

Eriksson, Anna; Engvall, Marie; Mathot, Lucy; Österroos, Albin et al.

Part of Clinical Cancer Research, p. 2826-2834, 2023

• DOI for Somatic Exonic Deletions in RUNX1 Constitutes a Novel Recurrent Genomic Abnormality in Acute Myeloid Leukemia

Proteogenomic analysis of acute myeloid leukemia associates relapsed disease with reprogrammed energy metabolism both in adults and children

Stratmann, Svea; Vesterlund, Mattias; Umer, Husen M.; Skaftason, Aron et al.

Part of Leukemia, p. 550-559, 2023

• DOI for Proteogenomic analysis of acute myeloid leukemia associates relapsed disease with reprogrammed energy metabolism both in adults and children
• Download full text (pdf) of Proteogenomic analysis of acute myeloid leukemia associates relapsed disease with reprogrammed energy metabolism both in adults and children

Managing leukemia patients via liquid biopsy and super rolling circle amplification (superRCA)

Robelius, Anna; Chen, Lei; Amini, Rose-Marie; Cavelier, Lucia et al.

Part of Journal of Internal Medicine, p. 228-237, 2023

• DOI for Managing leukemia patients via liquid biopsy and super rolling circle amplification (superRCA)

Characterization of therapy-related acute myeloid leukemia: increasing incidence and prognostic implications

Nilsson, Christer; Linde, Fredrika; Hulegardh, Erik; Garelius, Hege et al.

Part of Haematologica, p. 1015-1025, 2023

• DOI for Characterization of therapy-related acute myeloid leukemia: increasing incidence and prognostic implications
• Download full text (pdf) of Characterization of therapy-related acute myeloid leukemia: increasing incidence and prognostic implications

Is it possible to increase the amount of physical activity in patients isolated due to hematopoietic stem cell transplantation using a nursing intervention?: A feasibility study

Vejby, Sölvi; Eriksson, Anna; Nordin, Karin; Johansson, Birgitta

Part of Nordic journal of nursing research, p. 18-27, 2022

• DOI for Is it possible to increase the amount of physical activity in patients isolated due to hematopoietic stem cell transplantation using a nursing intervention?: A feasibility study
• Download full text (pdf) of Is it possible to increase the amount of physical activity in patients isolated due to hematopoietic stem cell transplantation using a nursing intervention?: A feasibility study

Transcriptomic analysis reveals proinflammatory signatures associated with acute myeloid leukemia progression

Stratmann, Svea; Yones, Sara A.; Garbulowski, Mateusz; Sun, Jitong et al.

Part of Blood Advances, p. 152-164, 2022

• DOI for Transcriptomic analysis reveals proinflammatory signatures associated with acute myeloid leukemia progression
• Download full text (pdf) of Transcriptomic analysis reveals proinflammatory signatures associated with acute myeloid leukemia progression

A risk score based on real-world data to predict early death in acute promyelocytic leukemia

Österroos, Albin; Maia, Tania; Eriksson, Anna; Jädersten, Martin et al.

Part of Haematologica, p. 1528-1537, 2022

• DOI for A risk score based on real-world data to predict early death in acute promyelocytic leukemia
• Download full text (pdf) of A risk score based on real-world data to predict early death in acute promyelocytic leukemia

Plasma protein biomarker profiling reveals major differences between acute leukaemia, lymphoma patients and controls

Sabaa, Amal Abu; Shen, Qiujin; Lennmyr, Emma; Enblad, Anna Pia et al.

Part of New Biotechnology, p. 21-29, 2022

• DOI for Plasma protein biomarker profiling reveals major differences between acute leukaemia, lymphoma patients and controls
• Download full text (pdf) of Plasma protein biomarker profiling reveals major differences between acute leukaemia, lymphoma patients and controls

Plasma proteome profiling of cardiotoxicity in patients with diffuse large B-cell lymphoma

Mörth, Charlott; Sabaa, Amal Abu; Freyhult, Eva; Christersson, Christina et al.

Part of Cardio-Oncology, 2021

• DOI for Plasma proteome profiling of cardiotoxicity in patients with diffuse large B-cell lymphoma
• Download full text (pdf) of Plasma proteome profiling of cardiotoxicity in patients with diffuse large B-cell lymphoma

Genomic characterization of relapsed acute myeloid leukemia reveals novel putative therapeutic targets

Stratmann, Svea; Yones, Sara A.; Mayrhofer, Markus; Norgren, Nina et al.

Part of Blood Advances, p. 900-912, 2021

• DOI for Genomic characterization of relapsed acute myeloid leukemia reveals novel putative therapeutic targets

Challenging conventional karyotyping by next-generation karyotyping in 281 intensively treated patients with AML

Mareschal, Sylvain; Palau, Anna; Lindberg, Johan; Ruminy, Philippe et al.

Part of Blood Advances, p. 1003-1016, 2021

• DOI for Challenging conventional karyotyping by next-generation karyotyping in 281 intensively treated patients with AML

Integrated transcriptomic and genomic analysis improves prediction of complete remission and survival in elderly patients with acute myeloid leukemia

Österroos, Albin; Björklund, My; Eriksson, Anna; Lindberg, Johan et al.

Part of Blood Cancer Journal, 2020

• DOI for Integrated transcriptomic and genomic analysis improves prediction of complete remission and survival in elderly patients with acute myeloid leukemia
• Download full text (pdf) of Integrated transcriptomic and genomic analysis improves prediction of complete remission and survival in elderly patients with acute myeloid leukemia

Real-world data on treatment patterns and outcomes of hypomethylating therapy in patients with newly diagnosed acute myeloid leukaemia aged ≥ 60 years

Österroos, Albin; Eriksson, Anna; Antunovic, Petar; Cammenga, Jörg et al.

Part of British Journal of Haematology, 2020

• DOI for Real-world data on treatment patterns and outcomes of hypomethylating therapy in patients with newly diagnosed acute myeloid leukaemia aged ≥ 60 years

Towards repositioning of quinacrine for treatment of acute myeloid leukemia - Promising synergies and in vivo effects.

Eriksson, Anna; Chantzi, Efthymia; Fryknäs, Mårten; Gullbo, Joachim et al.

Part of Leukemia Research, p. 41-46, 2017

• DOI for Towards repositioning of quinacrine for treatment of acute myeloid leukemia - Promising synergies and in vivo effects.
• Download full text (pdf) of Towards repositioning of quinacrine for treatment of acute myeloid leukemia - Promising synergies and in vivo effects.

Combination screening in vitro identifies synergistically acting KP372-1 and cytarabine against acute myeloid leukemia

Österroos, Albin; Kashif, Muhammad; Haglund, Caroline; Blom, Kristin et al.

Part of Biochemical Pharmacology, p. 40-49, 2016

• DOI for Combination screening in vitro identifies synergistically acting KP372-1 and cytarabine against acute myeloid leukemia

Repositioning Of Quinacrine For Treatment Of Acute Myeloid Leukemia - Synergies And In Vivo Effects

Eriksson, Anna; Gustafsson, Mats; Fryknäs, Mårten; Gullbo, Joachim et al.

Part of Haematologica, p. 367-368, 2016

Drug screen in patient cells suggests quinacrine to be repositioned for treatment of acute myeloid leukemia

Eriksson, Anna; Österroos, Albin; Hassan, Sadia Bashir; Gullbo, Joachim et al.

Part of Blood Cancer Journal, 2015

• DOI for Drug screen in patient cells suggests quinacrine to be repositioned for treatment of acute myeloid leukemia
• Download full text (pdf) of Drug screen in patient cells suggests quinacrine to be repositioned for treatment of acute myeloid leukemia

Development of a Progress Test Based on the EHA Curriculum and EHA CV Passport, Used for Yearly Evaluation of Hematology Residency In Sweden

Ungerstedt, J.; Eriksson, Anna; Olander, E.; Bergfelt, Emma et al.

Part of Haematologica, p. 776-776, 2015

Epigenetic aberrations in acute myeloid leukemia: Early key events during leukemogenesis

Eriksson, Anna; Lennartsson, Andreas; Lehmann, Sören

Part of Experimental Hematology, p. 609-624, 2015

• DOI for Epigenetic aberrations in acute myeloid leukemia: Early key events during leukemogenesis

Development of Progress Test Based on EHA Curriculum and EHA CV Passport, Used for Yearly Evaluation of Hematology Residency in Sweden

Ungerstedt, J.; Eriksson, Anna; Olander, E.; Theander, J. et al.

Part of Haematologica, p. 788-788, 2014

AKN-028 induces cell cycle arrest, downregulation of Myc associated genes and a dose dependent reduction of kinase activity in acute myeloid leukemia

Eriksson, Anna; Kalushkova, Antonia; Jarvius, Malin; Hilhorst, Riet et al.

Part of Biochemical Pharmacology, p. 284-291, 2014

• DOI for AKN-028 induces cell cycle arrest, downregulation of Myc associated genes and a dose dependent reduction of kinase activity in acute myeloid leukemia
• Download full text (pdf) of AKN-028 induces cell cycle arrest, downregulation of Myc associated genes and a dose dependent reduction of kinase activity in acute myeloid leukemia

Repositioning of Quinacrine for Treatment of Acute Myeloid Leukemia

Eriksson, Anna; Osterros, Albin; Hassan, Sadia Bashir; Gullbo, Joachim et al.

Part of Blood, 2014

The novel tyrosine kinase inhibitor AKN-028 has significant antileukemic activity in cell lines and primary cultures of acute myeloid leukemia

Eriksson, Anna; Hermanson, Monica; Wickström, Malin; Lindhagen, Elin et al.

Part of Blood Cancer Journal, 2012

• DOI for The novel tyrosine kinase inhibitor AKN-028 has significant antileukemic activity in cell lines and primary cultures of acute myeloid leukemia

Identification of AKN-032, a novel 2-aminopyrazine tyrosine kinase inhibitor, with significant preclinical activity in acute myeloid leukemia

Eriksson, Anna; Höglund, Martin; Lindhagen, Elin; Åleskog, Anna et al.

Part of Biochemical Pharmacology, p. 1507-1516, 2010

• DOI for Identification of AKN-032, a novel 2-aminopyrazine tyrosine kinase inhibitor, with significant preclinical activity in acute myeloid leukemia

Studies of New Signal Transduction Modulators in Acute Myeloid Leukemia

Eriksson, Anna

2012

• Download full text (pdf) of Studies of New Signal Transduction Modulators in Acute Myeloid Leukemia

SUPPLEMENTARY MATERIAL: Transcriptomic analysis reveals pro-inflammatory signatures associated with acute myeloid leukemia progression

Stratmann, Svea; Yones, Sara A.; Garbulowski, Mateusz; Sun, Jitong et al.

2021

SUPPLEMENTAL INFORMATION FOR: Transcriptomic analysis reveals pro-inflammatory signatures associated with acute myeloid leukemia progression

Stratmann, Svea; Yones, Sara A.; Garbulowski, Mateusz; Sun, Jitong et al.

2020

• Download full text (pdf) of SUPPLEMENTAL INFORMATION FOR: Transcriptomic analysis reveals pro-inflammatory signatures associated with acute myeloid leukemia progression

Integrated multi-omic profiling of azacitidine-venetoclax in AML reveals additional targetable pathways to improve the treatment

Österroos, Albin; Zhong, Xiangfu; Gamboa Cedeno, Angelica; Junkunlo, Kingkamon et al.

T-cell Leukaemia/Lymphoma Protein 1A (TCL1A) In Diffuse Large B-cell lymphoma (DLBCL)

Abu Sabaa, Amal; Mörth, Charlott; Berglund, Mattias; Hashemi, Jamileh et al.

Plasma Protein Profiling using Multiplex Extension Assay in Diffuse large B-cell lymphoma (DLBCL) treated with R-CHOP: A descriptive study

Abu Sabaa, Amal; Mörth, Charlott; Molin, Daniel; Freyhult, Eva et al.